Whether Using Sequential pH Would Improve Human Blastocyst Formation

July 14, 2019 updated by: Muhammad Fawzy, Ibn Sina Hospital

Sequential pH Effect on Blastocyst Formation Rate

Any drift in extracellular pH (pHe) from the intercellular pH (pHi) could alter the mechanism regulating transporters and exchangers through the plasma membrane. This could lead to difficulty in restoring the physiological level of pHi. The critical stages that lack robust mechanism of regulating the pHi are the denuded oocyte, early stage of fertilization or a thawed embryo. This, in turn, could lead to a significant effect of the perturbations on embryo development. Convincing evidence regarding the optimal pHe for culturing human embryo is, so far, scanty and mostly anecdotal. The embryo has been reported to have a compensatory mechanism to grow at pHe between 7.0-7.4. Others have recommended that embryo need a sequential pH to viably grow suggesting that the post-genomic activation stage needs a slightly alkaline range of pH. However, whether this holds true remains to be examined.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

1312

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt
        • Banon Assiut
      • Quena, Egypt, 12346
        • Quena IVF Centre
      • Sohag, Egypt, 12345
        • IbnSina IVF Center, IbnSina Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • ICSI cycles

Exclusion Criteria:

  • No exclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Sequential pH culture (7.23 then 7.35)
A split embryo at day 3 to continue culture at a pHe of 7.23±0.02 or to be cultured at a pH of 7.35±0.02 and monitor the effect on blastocyst development.
to investigate which pH is suitable for each stage of embryo development
NO_INTERVENTION: Continuously pH culture at 7.23
Embryo culture from day 0 to 5 or 6 at 7.23

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ongoing Pregnancy rate
Time Frame: 12 weeks
women with continued pregnancy at week 12 of gestation
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of usable blastocysts
Time Frame: 6 days of culture
number of blastocysts suitable for transfer on day 5 or 6
6 days of culture
Blastocyst formation rate
Time Frame: 6 days of culture
number of formed blastocyst per Fertilized oocyte
6 days of culture
Clinical pregnancy rate
Time Frame: 3 months
number of women with ultrasound detection of sacs with heartbeat per stimulated cycle
3 months
Implantation rate
Time Frame: 7 weeks
number of sacs with a heartbeat
7 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 28, 2018

Primary Completion (ACTUAL)

May 30, 2019

Study Completion (ACTUAL)

June 10, 2019

Study Registration Dates

First Submitted

August 10, 2018

First Submitted That Met QC Criteria

August 20, 2018

First Posted (ACTUAL)

August 21, 2018

Study Record Updates

Last Update Posted (ACTUAL)

July 16, 2019

Last Update Submitted That Met QC Criteria

July 14, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IbnSina-Sequential pH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on pH Effect on blastocyst formation

3
Subscribe